spot_img

Celiac

HomeDiseaseCeliac

New findings show the effectiveness of a promising drug for celiac disease at a molecular level

A recent study investigated whether a transglutaminase 2 inhibitor has potential as a drug to treat celiac disease. Previous tissue studies have shown that the ZED1227 transglutaminase 2 inhibitor prevents gluten-induced intestinal damage. The results of the new study, based on an analysis of the molecular activity of more than 10,000 genes, provide very strong
admin - 0

Understanding Celiac Disease: Latest Insights on Gluten’s Impact

0

― Advertisement ―

spot_img

New findings show the effectiveness of a promising drug for celiac disease at a molecular level

A recent study investigated whether a transglutaminase 2 inhibitor has potential as a drug to treat celiac disease. Previous tissue studies have shown that the ZED1227 transglutaminase 2 inhibitor prevents gluten-induced intestinal damage. The results of the new study, based on an analysis of the molecular activity of more than 10,000 genes, provide very strong

More News

New findings show the effectiveness of a promising drug for celiac disease at a molecular level

A recent study investigated whether a transglutaminase 2 inhibitor has potential as a drug to treat celiac disease. Previous tissue studies have shown that the ZED1227 transglutaminase 2 inhibitor prevents gluten-induced intestinal damage. The results of the new study, based on an analysis of the molecular activity of more than 10,000 genes, provide very strong

Understanding Celiac Disease: Latest Insights on Gluten’s Impact

Condition affecting around one per cent of the global population. Triggered by gluten consumption, it causes severe intestinal damage. To combat this, a gluten-free diet is crucial for celiac patients. On International Celiac Day, let's raise awareness about this condition and the importance of managing it through proper dietary measures
spot_img

Explore more

New findings show the effectiveness of a promising drug for celiac disease at a molecular level

admin -
A recent study investigated whether a transglutaminase 2 inhibitor has potential as a drug to treat celiac disease. Previous tissue studies have shown that the ZED1227 transglutaminase 2 inhibitor prevents gluten-induced intestinal damage. The results of the new study, based on an analysis of the molecular activity of more than 10,000 genes, provide very strong

Understanding Celiac Disease: Latest Insights on Gluten’s Impact

admin -
Condition affecting around one per cent of the global population. Triggered by gluten consumption, it causes severe intestinal damage. To combat this, a gluten-free diet is crucial for celiac patients. On International Celiac Day, let's raise awareness about this condition and the importance of managing it through proper dietary measures

@2017 YSL News all right reseved